Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Abeona Therapeutics (ABEO) EPS (Weighted Average and Diluted): 2012-2024

Historic EPS (Weighted Average and Diluted) for Abeona Therapeutics (ABEO) over the last 6 years, with Dec 2024 value amounting to -$1.55.

  • Abeona Therapeutics' EPS (Weighted Average and Diluted) rose 84.13% to -$0.10 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.23, marking a year-over-year increase of 145.72%. This contributed to the annual value of -$1.55 for FY2024, which is 38.74% up from last year.
  • Abeona Therapeutics' EPS (Weighted Average and Diluted) amounted to -$1.55 in FY2024, which was up 38.74% from -$2.53 recorded in FY2023.
  • In the past 5 years, Abeona Therapeutics' EPS (Weighted Average and Diluted) registered a high of -$1.55 during FY2024, and its lowest value of -$5.53 during FY2022.
  • Over the past 3 years, Abeona Therapeutics' median EPS (Weighted Average and Diluted) value was -$2.53 (recorded in 2023), while the average stood at -$3.20.
  • Data for Abeona Therapeutics' EPS (Weighted Average and Diluted) shows a peak YoY skyrocketed of 54.25% (in 2023) over the last 5 years.
  • Over the past 3 years, Abeona Therapeutics' EPS (Weighted Average and Diluted) (Yearly) stood at -$5.53 in 2022, then surged by 54.25% to -$2.53 in 2023, then spiked by 38.74% to -$1.55 in 2024.